Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications
about
Cytokine-Induced Modulation of Colorectal CancerTumor-platelet interaction in solid tumorsHypoxia triggers a Nur77-β-catenin feed-forward loop to promote the invasive growth of colon cancer cells.Efficacy of pEgr-1-endostatin combined with ionizing radiation on hypoxic conditions in nude mice bearing SKOV3 ovarian carcinoma.VEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer.Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancerZiv-aflibercept in metastatic colorectal cancerHypoxia and lineage specification of cell line-derived colorectal cancer stem cellsInterleukin-24 is correlated with differentiation and lymph node numbers in rectal cancer.The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse.Prognostic value and clinicopathological differences of HIFs in colorectal cancer: evidence from meta-analysis.Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies.Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer.Role of compartmentalization on HiF-1α degradation dynamics during changing oxygen conditions: a computational approach.Chronic ethanol feeding promotes azoxymethane and dextran sulfate sodium-induced colonic tumorigenesis potentially by enhancing mucosal inflammationEstablishment of a colorectal cancer nude mouse visualization model of HIF-1α overexpression.Hypoxia-Inducible Factor-1α Expression in Indonesian Laryngeal Squamous Cell Carcinoma PatientsIndirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery.Obesity, energy balance, and cancer: new opportunities for preventionNo associations of a set of SNPs in the Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinase (MMP) genes with survival of colorectal cancer patientsIncreased Tumor Ascorbate is Associated with Extended Disease-Free Survival and Decreased Hypoxia-Inducible Factor-1 Activation in Human Colorectal CancerThe mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia.Molecular responses to hypoxia-inducible factor 1α and beyond.Defining the Balance between Regeneration and Pathological Ossification in Skeletal Muscle Following Traumatic Injury.Hypoxia-mediated biological control.Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.Hypoxia inducible factor-1 alpha and multiple myeloma.Anti-angiogenic and anti-proliferative effects of inhibition of HIF-1α by p-HIF-1α RNAi in colorectal cancerAnti-tumor effect of the mammalian target of rapamycin inhibitor everolimus in oral squamous cell carcinoma.HIF-1α and VEGF: Immunohistochemical Profile and Possible Function in Human Aortic Valve Stenosis.Partial Oxygen Pressure Affects the Expression of Prognostic Biomarkers HIF-1 Alpha, Ki67, and CK20 in the Microenvironment of Colorectal Cancer Tissue.Treatment with an activator of hypoxia-inducible factor 1, DMOG provides neuroprotection after traumatic brain injury.Expression of hypoxia inducible factor-1α and its significance in laryngeal carcinoma.GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions.Metabolic remodeling in human colorectal cancer and surrounding tissues: alterations in regulation of mitochondrial respiration and metabolic fluxes."Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer.Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases.The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis.Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines.Metabolic Reprogramming in Thyroid Carcinoma.
P2860
Q26752374-AC6A0987-7E1D-4456-B8BC-A692AE17C95CQ26853099-74128B82-DD75-41E8-9C01-1B25E173BB30Q30408026-E37EA49C-C4FC-4228-B5CA-97BEA74C824DQ33598166-01D4E7C6-A7B4-48E6-B221-25379897DEA7Q34551161-1C3BF061-FEED-4761-9D10-BBC042D0C9C4Q34577576-1202F211-04FA-4A91-A75C-41647BF21D24Q34658579-F0CEE121-05A5-4B22-BDCD-7F0577C45FA4Q34693614-BD13A84F-585A-477C-964C-18BA85775E71Q34717408-84C0B9DC-689B-4906-BF49-46C1B89F2065Q34806020-06F07D9D-2210-4DD2-ADF1-6AE179D13696Q35063723-5E8076AF-41C5-4154-8518-C8A6B5CADCEAQ35113402-984C178D-F2D7-4755-9715-A1392D1066D4Q35121518-02E55B26-2F92-4D94-A7BA-AFE79B396C98Q35358870-3A9D62B3-46CE-4A67-8FF9-32371A9AF064Q35948499-584EE4EC-A06D-4FDF-8E01-A5EC8535198AQ35988042-6B8D48C1-8143-49CA-BCEE-178E082E0878Q36203139-91B5D177-466F-4FED-8A73-27316A668106Q36509821-73CD629B-2771-4096-B9B2-C92AAC6A33F3Q36810924-DA98A21B-8A26-4085-BF01-6471F1987A9DQ37321136-EC4F10CE-BF25-4C33-A22F-FF8EF6568F94Q37550889-8A199AF7-4AF6-4876-8B0A-26F07C8A3583Q37654508-49B01139-8608-4039-9EE6-5A964BDF3E26Q37708123-1BD9BE44-BA92-44EF-89D1-7A06151C8577Q37733728-E7C0F0C2-20DE-40AA-810F-2035BE106B11Q37843943-57FEFB1E-8E7C-4FF5-925E-745BFC6E9541Q37860943-91B06B5F-C0C3-427A-87F7-C29A51A4F729Q38567828-05B24D4B-7642-4888-AFF3-1741B59F7047Q38838024-FC637A16-223E-45E2-8C9D-58E14A0DE561Q39038881-5640D144-7701-4C83-920C-D4DBC81177A1Q41608987-84D4E09C-299B-40B9-9444-D1A1C505248CQ41860766-6DA284FE-E6E3-427A-B6BC-BC1DE07BC2AAQ42214423-0784E08C-FB41-4401-8502-2AE916FBA1D6Q42758514-E5949B30-67C5-4E9B-A028-1B18771CB72DQ45740789-E4F20E31-857D-4644-B777-A17061879B53Q47110867-E05BDBF2-AA3B-4797-B534-B749A8BE6337Q48207420-563A4077-4025-40A4-99B4-AE293D5ADA18Q50924734-B2C94217-61A3-410B-8AF1-D06792B4EBDDQ51017220-7145E488-0DBD-446F-A469-1D6A8937EF29Q53584232-1A4953EC-63B4-4D32-8A8A-9F85F3DD9972Q53697345-E24EE7B9-759F-48D7-9723-9AAAC65DBC4E
P2860
Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Expression of HIF-1alpha and V ...... es and prognostic implications
@ast
Expression of HIF-1alpha and V ...... es and prognostic implications
@en
Expression of HIF-1alpha and V ...... s and prognostic implications.
@nl
type
label
Expression of HIF-1alpha and V ...... es and prognostic implications
@ast
Expression of HIF-1alpha and V ...... es and prognostic implications
@en
Expression of HIF-1alpha and V ...... s and prognostic implications.
@nl
prefLabel
Expression of HIF-1alpha and V ...... es and prognostic implications
@ast
Expression of HIF-1alpha and V ...... es and prognostic implications
@en
Expression of HIF-1alpha and V ...... s and prognostic implications.
@nl
P2093
P2860
P356
P1433
P1476
Expression of HIF-1alpha and V ...... es and prognostic implications
@en
P2093
P2860
P2888
P356
10.1186/1471-2407-9-432
P407
P577
2009-12-10T00:00:00Z
P5875
P6179
1006220407